Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
Goldney J, Sargeant JA, Davies MJ
Diabetologia. Pub. online 19 Aug 2023.
Leggi
Breaking news
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study
Kosjerina V, Carstensen B, Amadid H, Vistisen D
Diabetologia. Pub. online 28 Jul 2023.
Leggi
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta‐analysis of randomized controlled trials
Iannone A, Natale P, Palmer SC, et al.
Diabetes Obes Metab. 2023;25(9):2535-2544.
Leggi
Associations of lipoprotein subclasses with risk of all‐cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study
Li R, Chen JX, Lu Q, et al.
Diabetes Obes Metab. Pub. online 26 Jul 2023.
Leggi
Adaptive bolus calculators for people with type 1 diabetes: A systematic review
Unsworth R, Avari P, Lett AM, et al.
Diabetes Obes Metab. Pub. online 24 Jul 2023.
Leggi
GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes
Neves JS, Borges-Canha M, Vasques-Nóvoa F, et al.
J Am Coll Cardiol. 2023;82 (6) 517–525.
Leggi
Safety of sodium‐glucose co‐transporter‐2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes
Park S, Jeong HE, Bea S, et al.
Diabetes Obes Metab. Pub. online 28 Jul 2023.
Leggi
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
Xie Y, Bowe B, Xian H, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00171-7.
Leggi
Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials
Balasubramanian P, Kernan WN, Sheth KN, et al.
Stroke. 2023;54(8):2013-2021.
Leggi